The association of lower activity of PI3K/AKT and potentially MTOR with the low muscle body composition type is in line with the observation that patients with cancer are at high risk of losing muscle, leading to sarcopenia or cachexia [32]. This evidence concerns the gene MTOR and Cachexia.